| Davis, ID and Long, A and Martin, A and Espinoza, D and Yip, S and Kichenadasse, G and Thompson, JF and Harrison, ML and Lowenthal, RM and Pavlakis, N and Azad, A and Kannourakis, G and Steer, C and Goldstein, D and Shapiro, JD and Stockler, MR, “EVERSUN: A phase II trial of everolimus alternating with sunitinib as first-line therapy for advanced renal cell carcinoma (aRCC) (ANZUP trial 0901)”, 2014 Genitourinary Cancers Symposium, January 30 - February 1, San Francisco, United States (2014) [Conference Extract] |
